Glomerulonephritis membranous – Life with Disease

Go back

Membranous glomerulonephritis, also known as membranous nephropathy, is a rare kidney disease where the immune system mistakenly attacks the tiny filters in the kidneys, potentially leading to serious complications if left untreated.

Prognosis and Long-Term Outlook

Understanding what to expect when living with membranous glomerulonephritis can help you and your family prepare for the journey ahead. The disease affects everyone differently, and the outlook varies greatly from person to person. This variability can feel uncertain, but knowing the possible paths the disease may take can provide some comfort and help with planning.

The prognosis for membranous nephropathy depends heavily on several factors, including whether you have the primary or secondary form of the disease, how quickly it was diagnosed, and how well your kidneys were functioning when treatment began. In primary membranous nephropathy, which accounts for about 75 to 80 percent of cases, the outcome can follow several different patterns.[2] Some patients experience what doctors call spontaneous remission, meaning the disease improves on its own without intensive treatment. Others may continue to lose protein in their urine but maintain stable kidney function for years. Unfortunately, some people will see their condition worsen over time, potentially leading to chronic kidney disease or even kidney failure.

For secondary membranous nephropathy, the outlook often depends on successfully treating the underlying cause. If you have this form because of an infection like hepatitis B or hepatitis C, treating the infection may lead to improvement in your kidney function. Similarly, if certain medications or toxins caused your condition, stopping the exposure can sometimes allow your kidneys to recover.[1] Cancer-related cases may improve if the cancer is successfully treated, though this varies considerably depending on the type and stage of cancer involved.

Research shows that several factors can help predict how the disease might progress. Men over age 50 tend to have a more challenging outlook compared to younger patients or women. High levels of protein loss in the urine, elevated creatinine levels at the time of diagnosis, and certain changes visible on kidney biopsy samples can all suggest a higher risk of progression to kidney failure.[8] The presence of antibodies against phospholipase A2 receptor, known as anti-PLA2R antibodies, is found in 70 to 80 percent of primary membranous nephropathy cases, and tracking the levels of these antibodies over time can help doctors predict whether you might go into remission or if the disease is likely to progress.[3]

⚠️ Important
If you have been diagnosed with membranous glomerulonephritis, regular monitoring is essential even if you feel well. The disease can progress silently for years without obvious symptoms, so staying in close contact with your kidney specialist and attending all scheduled appointments is crucial for catching any changes early when treatment can be most effective.

Natural Progression Without Treatment

When membranous glomerulonephritis is left untreated, the disease can take several different courses, and understanding these possibilities is important for making informed decisions about your care. The natural history of this condition is quite variable, which means that what happens to one person may be very different from what happens to another, even if both started with similar symptoms.

In approximately one-quarter to one-third of people with primary membranous nephropathy, the condition resolves on its own without any specific treatment beyond supportive care. This spontaneous remission usually occurs within the first few years after diagnosis and is more common in people who have lower levels of protein in their urine and better kidney function at the start.[4] However, waiting to see if spontaneous remission occurs carries risks, as the disease may worsen during this observation period.

Another group of patients, roughly one-quarter to one-third, will experience persistent protein loss in their urine but maintain relatively stable kidney function for many years. These individuals may live with the symptoms of nephrotic syndrome, which is the collection of symptoms caused by large amounts of protein leaking into the urine, including swelling, fatigue, and high cholesterol, but their kidneys continue to filter waste adequately. This middle ground can last for a decade or more in some cases, though the ongoing protein loss does put strain on the kidneys and other body systems.

The remaining patients, approximately 30 to 50 percent of those with untreated primary membranous nephropathy, will see their kidney function gradually decline over time. This progression to chronic kidney disease can happen slowly over many years or more rapidly in some cases. Without treatment, these individuals may eventually develop end-stage renal disease, which is complete kidney failure requiring dialysis or kidney transplantation to sustain life.[16] The speed of progression varies widely, with some people reaching kidney failure within a few years while others maintain partial kidney function for a decade or more.

Several factors influence which path the disease will take. People with very high levels of protein in their urine at diagnosis, particularly those losing more than 8 to 10 grams of protein per day, are more likely to experience progressive kidney damage. Elevated blood pressure and reduced kidney function at the time of diagnosis also increase the likelihood of continued decline. Additionally, the presence of certain findings on kidney biopsy, such as scarring of the small blood vessels or damage to the kidney tissue beyond the filters themselves, suggests a higher risk of progression.[12]

Possible Complications

Membranous glomerulonephritis can lead to various complications that affect different parts of your body and significantly impact your health. Understanding these potential complications helps you recognize warning signs early and seek appropriate medical attention when needed.

One of the most serious complications is the development of blood clots, which occurs more frequently in people with membranous nephropathy than in the general population. The massive loss of protein in your urine includes proteins that normally prevent clot formation, while your liver produces more clotting proteins in an attempt to compensate for the overall protein loss. This imbalance creates a state where your blood clots more easily than it should.[1] Deep vein thrombosis, which is a blood clot in the deep veins of your legs, can occur and may break loose to travel to your lungs, causing a potentially life-threatening condition called pulmonary embolism. Blood clots can also form in the kidney veins themselves, a condition called renal vein thrombosis, which can further damage kidney function.

The risk of blood clots increases significantly when the level of albumin in your blood drops below certain thresholds. Studies have shown that the risk of developing blood clots increases nearly four times when serum albumin falls below 2.8 grams per deciliter, and nearly six times when it drops below 2.2 grams per deciliter.[8] Because of this elevated risk, some doctors may recommend blood-thinning medications even before a clot develops, particularly if your albumin levels are very low.

High cholesterol and other blood fat abnormalities are nearly universal in people with active membranous nephropathy. When your kidneys leak albumin into the urine, your liver responds by producing more proteins, including cholesterol and triglycerides. This leads to significantly elevated levels of fats in your blood, which over time can contribute to hardening of the arteries, heart attacks, and strokes. The abnormal cholesterol levels in membranous nephropathy can be much higher than those seen in people with familial high cholesterol, sometimes reaching levels two or three times the normal range.[5]

Infections become more likely when you have membranous nephropathy, particularly if you are taking immunosuppressive medications to treat the condition. The loss of antibodies and other immune proteins in your urine weakens your immune system’s ability to fight off bacteria, viruses, and other pathogens. People with nephrotic syndrome are particularly vulnerable to infections from encapsulated bacteria, which can cause serious pneumonia and bloodstream infections. This is why vaccination against pneumonia and influenza is strongly recommended for everyone with membranous nephropathy.[18]

Severe swelling, or edema, can become debilitating as the disease progresses. The loss of albumin means less protein remains in your bloodstream to hold water inside your blood vessels, so fluid leaks into your tissues. This can cause massive swelling of your legs, feet, and ankles, as well as fluid accumulation around your lungs (pleural effusion) or in your abdominal cavity (ascites). The swelling can become so severe that it interferes with walking, breathing, and other basic activities.[1]

High blood pressure develops in many people with membranous nephropathy and can contribute to further kidney damage, creating a harmful cycle. The kidneys play a crucial role in regulating blood pressure, and when they are damaged, they may signal the body to retain more salt and water, raising blood pressure. Uncontrolled high blood pressure, in turn, damages the small blood vessels in the kidneys, accelerating the progression toward kidney failure.[5]

⚠️ Important
Watch for sudden leg pain, swelling in one leg more than the other, chest pain, or sudden difficulty breathing, as these could be signs of blood clots requiring immediate medical attention. Similarly, fever, confusion, severe headache, or other signs of infection should prompt you to contact your healthcare provider right away, especially if you are taking immunosuppressive medications.

Impact on Daily Life

Living with membranous glomerulonephritis affects nearly every aspect of daily life, from physical capabilities to emotional wellbeing, social relationships, and work responsibilities. Understanding these impacts and learning strategies to cope with them can help you maintain the best possible quality of life while managing this chronic condition.

Physical limitations often stem from the severe swelling that accompanies the disease. When your legs and feet are swollen, simple activities like walking to the mailbox, climbing stairs, or standing to prepare meals become exhausting and uncomfortable. The swelling can make it difficult to fit into regular shoes, requiring you to wear larger or special footwear. Some people find that their hands become so swollen that gripping objects, typing, or performing detailed work becomes challenging. The fatigue that accompanies membranous nephropathy can be profound, leaving you feeling drained even after a full night’s sleep.[5] This exhaustion results partly from anemia, which commonly develops as kidney function declines, and partly from the metabolic stress of losing so much protein.

Dietary restrictions become necessary to manage the symptoms and slow disease progression. Your doctor or dietitian will likely recommend reducing your salt intake significantly to help control swelling and blood pressure. This means avoiding processed foods, restaurant meals, and many convenience foods that are high in sodium. You may also need to limit protein intake to reduce the workload on your kidneys, though this must be balanced carefully to ensure you still get adequate nutrition given the protein loss in your urine. Managing potassium and phosphorus levels may become necessary as kidney function declines. These dietary changes can feel overwhelming at first and may affect your social life, as sharing meals with friends and family becomes more complicated.[5]

The emotional toll of living with a chronic, potentially progressive kidney disease should not be underestimated. Many people experience anxiety about their future, particularly fears about potentially needing dialysis or a kidney transplant. The uncertainty of not knowing whether the disease will go into remission, remain stable, or progress can be mentally exhausting. Depression is common among people with chronic kidney disease, and the physical symptoms of membranous nephropathy, such as fatigue and difficulty engaging in previously enjoyed activities, can worsen mood problems. Some medications used to treat the disease, particularly corticosteroids, can also affect mood and emotional stability.[13]

Work and career may be affected in various ways. Frequent medical appointments for blood tests, urine tests, and visits with your nephrologist and other specialists can disrupt your work schedule. If your job requires physical labor or long periods of standing, the swelling and fatigue may make it difficult to perform your duties. Some immunosuppressive treatments can make you more vulnerable to infections, which might be concerning if you work in healthcare, education, or other settings with high exposure to germs. The cognitive effects of uremia, which can occur as kidney function declines, may impact concentration and decision-making abilities in jobs requiring mental focus.

Social relationships and activities often require adjustment. The fatigue and physical limitations may reduce your ability to participate in social events, sports, recreational activities, and hobbies you once enjoyed. Travel becomes more complicated as you need to coordinate with your medical care, manage dietary restrictions, and ensure you have adequate supplies of medications. Some people feel self-conscious about visible swelling or other physical changes caused by the disease or its treatment, such as weight gain from corticosteroids. Open communication with friends and family about your limitations and needs can help maintain these important relationships while navigating the challenges of the disease.[13]

Coping strategies that many people find helpful include pacing yourself throughout the day, alternating periods of activity with rest, and prioritizing the most important tasks. Elevating your legs when sitting or lying down can help reduce swelling. Wearing compression stockings may also provide relief, though you should discuss this with your doctor first. Connecting with support groups, either in person or online, can help you feel less isolated and learn practical tips from others living with similar challenges. Working with a mental health professional who understands chronic illness can provide valuable support for managing anxiety, depression, and the emotional aspects of living with kidney disease.

Support for Family Members and Clinical Trial Participation

When someone in your family has membranous glomerulonephritis, the entire family unit is affected, and family members play a crucial role in supporting the patient’s journey, including potential participation in clinical trials. Understanding how to help and what to expect can make a significant difference in managing this challenging condition together.

Family members should first understand that clinical trials are research studies designed to test new treatments, diagnostic approaches, or ways of managing membranous nephropathy. These trials are essential for advancing medical knowledge and developing better treatments for this rare disease. Clinical trials for kidney diseases go through several phases, starting with small safety studies and progressing to larger studies that compare new treatments with existing ones. While some people worry about the safety of clinical trials, they are carefully designed with multiple safeguards to protect participants, and researchers must follow strict ethical guidelines.[9]

Relatives can help patients explore clinical trial options by researching available studies together. Several online databases list ongoing clinical trials, and your loved one’s nephrologist may be aware of relevant studies. When reviewing potential trials, help your family member understand the purpose of the study, what participation involves, potential benefits and risks, and how the trial fits with their current treatment plan. Not all patients are eligible for every trial, as researchers often have specific criteria regarding disease stage, previous treatments, age, and other health conditions. Family members can assist by organizing medical records and documentation needed for trial screening.[9]

Understanding what participation entails helps families prepare practically and emotionally. Clinical trials typically require more frequent visits to the medical center than standard care, including additional blood tests, urine tests, kidney biopsies, or imaging studies. There may be detailed questionnaires about symptoms, quality of life, and side effects. Some trials are randomized, meaning the patient might receive the experimental treatment or a placebo or standard treatment, and neither the patient nor the doctors initially know which group they are in. This randomization is scientifically necessary to determine if new treatments truly work, but it can feel frustrating if you hope to receive a specific experimental therapy.

Financial considerations around clinical trials often confuse families. In most cases, the experimental treatment itself is provided at no cost, and the research sponsor typically pays for tests and procedures required specifically for the research. However, standard medical care costs may still apply, and insurance should cover these as they would outside of a trial. Transportation to the study center, parking, and time away from work are generally not reimbursed, though some trials offer modest stipends or assistance. Family members can help by discussing these practical matters with the research coordinator and planning accordingly.[9]

Relatives can provide invaluable support by accompanying the patient to appointments, helping them remember and understand complex medical information, tracking symptoms and medication side effects, and advocating for their needs with the research team. Keeping a journal of symptoms, questions, and observations can be helpful. Family members should feel empowered to ask the research team questions at any time and should understand that participants always have the right to withdraw from a trial if they choose, for any reason, without affecting their regular medical care.

Emotional support becomes particularly important if the patient experiences side effects from the experimental treatment or if the trial results are disappointing. Clinical trials do not always show benefit, and the experimental treatment might not work better than existing options, or might even cause unexpected problems. Helping your loved one maintain perspective, reminding them that their participation contributes to scientific knowledge that may help future patients, and supporting their decision whether to continue or withdraw can be enormously valuable.

Finding reliable information about clinical trials can be done through several resources. The Kidney Disease Clinical Trial Directory is specifically designed for kidney conditions. The national registry at clinicaltrials.gov lists all registered studies in the United States. Patient advocacy organizations for kidney disease often maintain lists of active trials and can provide guidance. The patient’s nephrologist may also be involved in research or know about relevant studies. When considering any clinical trial, make sure it is registered, approved by an ethics committee or institutional review board, and conducted at a reputable medical institution.[9]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Cyclophosphamide – An alkylating chemotherapy agent used in combination with corticosteroids for immunosuppressive therapy in severe cases
  • Chlorambucil – An alkylating agent used as an alternative immunosuppressive treatment, typically combined with corticosteroids
  • Corticosteroids (including Prednisone and Prednisolone) – Anti-inflammatory medications that suppress the immune system and reduce kidney inflammation
  • Cyclosporine – A calcineurin inhibitor that suppresses the immune system and has been used as an alternative to alkylating agents
  • Tacrolimus – A calcineurin inhibitor used for immunosuppression in membranous nephropathy treatment
  • Rituximab – A monoclonal antibody against CD20 on B lymphocytes, currently considered first-line treatment for membranous nephropathy
  • ACE inhibitors (Angiotensin-Converting Enzyme Inhibitors) – Medications that reduce blood pressure and decrease protein loss in urine
  • ARBs (Angiotensin II Receptor Blockers) – Used for patients intolerant of ACE inhibitors to control blood pressure and reduce proteinuria
  • Diuretics (including Loop Diuretics) – Medications that help control fluid retention and swelling
  • Statins – Lipid-lowering medications used to treat the high cholesterol associated with membranous nephropathy

Ongoing Clinical Trials on Glomerulonephritis membranous

  • Study of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases

    Recruiting

    1 1
    Investigated drugs:
    Belgium France Germany Italy Poland Spain
  • Evaluating Dapagliflozin’s Effect on Immune Activity in Patients with Membranous Nephropathy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of obinutuzumab to reduce PLA2R antibodies in patients with primary membranous nephropathy

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Italy Poland Spain
  • Study of Peginterferon Alfa-2a for Patients with Extramembranous Glomerulonephritis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

References

https://my.clevelandclinic.org/health/diseases/21154-membranous-nephropathy

https://www.ncbi.nlm.nih.gov/books/NBK559169/

https://en.wikipedia.org/wiki/Membranous_glomerulonephritis

https://emedicine.medscape.com/article/239799-overview

https://www.erknet.org/patients/your-kidney-disease/membranous-glomerulonephritis/disease-information

https://www.mayoclinic.org/diseases-conditions/glomerulonephritis/symptoms-causes/syc-20355705

https://www.healthline.com/health/membranous-nephropathy

https://emedicine.medscape.com/article/239799-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC9114510/

https://my.clevelandclinic.org/health/diseases/21154-membranous-nephropathy

https://pubmed.ncbi.nlm.nih.gov/36938069/

https://bestpractice.bmj.com/topics/en-us/941

https://my.clevelandclinic.org/health/diseases/21154-membranous-nephropathy

https://www.kidney.org/kidney-topics/glomerulonephritis

https://www.healthline.com/health/membranous-nephropathy

https://www.ncbi.nlm.nih.gov/books/NBK559169/

https://www.kidneyfund.org/living-kidney-disease/healthy-eating-activity

https://www.nhs.uk/conditions/glomerulonephritis/treatment/

https://www.mayoclinic.org/diseases-conditions/glomerulonephritis/symptoms-causes/syc-20355705

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can membranous glomerulonephritis go away on its own without treatment?

Yes, approximately one-quarter to one-third of people with primary membranous nephropathy experience spontaneous remission, meaning the disease improves without intensive treatment. This is more likely to occur in people with lower protein levels in their urine and better kidney function at diagnosis. However, since it’s impossible to predict who will experience spontaneous remission, doctors carefully monitor all patients and may recommend treatment if the disease appears likely to progress.

How is membranous glomerulonephritis different from other types of kidney disease?

Membranous glomerulonephritis is a specific type of glomerular disease where the immune system attacks the filtering membranes in the kidneys, causing them to thicken and leak protein. Unlike nephritic syndromes that involve inflammation and blood in the urine, membranous nephropathy typically causes massive protein loss without significant blood or inflammatory cells in the urine. It’s also different from diabetic kidney disease or high blood pressure-related kidney damage, as it involves an autoimmune process rather than metabolic or vascular damage.

Will I definitely need dialysis or a kidney transplant if I have membranous nephropathy?

Not necessarily. The disease follows different courses in different people. Some experience spontaneous remission, others maintain stable kidney function for many years with treatment, and approximately 30-50% of untreated patients progress to kidney failure over time. With modern treatments, particularly rituximab and other immunosuppressive therapies, many people can achieve remission and preserve their kidney function. Regular monitoring and appropriate treatment significantly improve the chances of avoiding dialysis or transplantation.

Is membranous glomerulonephritis contagious or genetic?

Membranous nephropathy is not contagious and cannot be spread from person to person. While the primary form is not directly inherited in a simple genetic pattern, there is a genetic component involving certain immune system genes (such as HLA-DQA1) that may increase susceptibility. However, most cases occur sporadically without a family history. Secondary forms may be associated with infections like hepatitis B or C, but it’s the individual’s immune response to these infections, not the infections themselves, that causes the kidney disease.

Can I still work and live a normal life with membranous glomerulonephritis?

Many people with membranous nephropathy continue working and maintaining active lives, though adjustments may be necessary. The extent depends on disease severity, symptoms like swelling and fatigue, treatment side effects, and your type of work. Some people function normally with minimal symptoms, while others need to reduce work hours or modify activities. With proper treatment, dietary management, and lifestyle adjustments, most patients can maintain a good quality of life. Open communication with your employer about medical appointments and physical limitations, when appropriate, can help you balance work and health needs.

🎯 Key takeaways

  • Membranous glomerulonephritis is a rare autoimmune kidney disease affecting only about 1 in 5,000 people, more commonly men over age 50
  • The discovery of anti-PLA2R antibodies in 2005 revolutionized diagnosis, as these antibodies are found in 70-80% of primary cases and can predict disease progression
  • About one-quarter to one-third of patients experience spontaneous remission without intensive treatment, though predicting who will improve remains challenging
  • Blood clot risk increases dramatically when albumin levels drop below certain thresholds, making this one of the most important complications to monitor and prevent
  • Rituximab has emerged as the preferred first-line treatment for primary membranous nephropathy, replacing older combinations of chemotherapy drugs and steroids in many cases
  • Successfully treating underlying causes like hepatitis infections or cancer can lead to improvement in secondary membranous nephropathy
  • Dietary modifications including low-sodium intake are essential for managing swelling and blood pressure, significantly impacting daily life and requiring family support
  • Clinical trials offer opportunities to access cutting-edge treatments while contributing to scientific knowledge that may help future patients with this rare disease